Interview: Wendy Adams – General Manager, Galderma Canada
Wendy Adams, general manager of Galderma Canada, outlines the main achievements of the affiliate since 2013, the best practices she can share with Galderma globally when it comes to managing…
Galderma is a leading global pharmaceutical company specializing in the research, development and marketing of innovative medical solutions in dermatology. Galderma’s important investments in R&D, extensive product portfolio, global presence and expertise in three key segments (prescription drugs, therapeutic skin care and aesthetic and corrective medical solutions) contribute to maintaining its strong leadership in dermatology. Galderma is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 31 wholly-owned affiliates with a worldwide network of distributors and more than 4,000 employees.
Galderma Canada Inc. offers a product portfolio to treat a range of dermatological conditions including: acne, eczema, rosacea, psoriasis and non-melanoma skin cancer.
Strategic brands include:
Tactuo® and Differin® (acne), MetroGel® and Apprilon™ (rosacea), Clobex® (psoriasis), Metvix® (skin cancer), Cetaphil® (therapeutic skin care)
Wendy Adams, general manager of Galderma Canada, outlines the main achievements of the affiliate since 2013, the best practices she can share with Galderma globally when it comes to managing…
Heather Chalmers, vice president and general manager of GE Healthcare Canada, shares the company’s increasing focus on incorporating applied intelligence and digital analytics in its portfolio of innovative solutions, and…
Lisa Purdy, who leads the healthcare & life sciences industry team in Canada and Kelley Dealhoy, global subject matter expert in life sciences M&A and external growth opportunities, discuss advantages…
With a diverse pipeline to back up its projects, Tetra Bio-Pharma wants to be the first Canadian pharmaceutical company to launch a cannabis-based drug in breakthrough pain. Bernard Fortier, CEO…
Heading Canada’s largest cannabis Business to Business Retailer, John Fowler, CEO of The Supreme Cannabis Company, offers a novel approach looking at medical cannabis as a medicine that is not…
Several smaller pharmaceutical companies – Taiho, Valneva, Mallinckrodt, Théa and Intercept Pharma – have chosen to set up operations in Canada very recently, recognizing the potential for product launches and development…
Despite Canada’s provincial approach to healthcare, Steve Gundersen, president of BD Canada’s operations, praises the collaborative spirit of healthcare stakeholders at all levels in order to overcome the challenges, such…
Red Leaf Medical, founded in 2009, is unique in its approach to the Canadian healthcare market, being the only company focused exclusively on urology solutions. Charles Ko, managing director, discusses…
Marc Wayne, serial entrepreneur and a pioneer within the field of medical cannabis discusses his dedication to the field, how cannabis-based therapies have the potential to disrupt the pharmaceutical industry…
Warren Bravo, co-founder and CEO of Green Relief, speaks about the company’s unique growing technique – aquaponics – which allows it to produce ‘better than organic’ medical cannabis. He gives…
Specializing on products adapted to the needs of seniors and long-term care patients, WeedMD is scaling up its production capacity to better meet the needs of this particular patient group…
Panalpina’s Dimitri Brink speaks about the main highlights of his first two years of tenure in the Canadian affiliate and how he brought the fully closed GDP (good distribution practices)…
Frank Baylis, chairman of the board at Baylis shares his views on his motivations for maintaining a lifelong interest in healthcare, the Baylis approach to problem solving, and sharing knowledge…
See our Cookie Privacy Policy Here
